Vertex Pharmaceuticals

Vertex Pharmaceuticals is a global biotechnology company focused on discovering, developing, and commercializing transformative medicines for serious diseases. Through strategic partnerships and investments, Vertex has been a pioneer in gene editing therapeutics, including their landmark collaboration with CRISPR Therapeutics that led to the first FDA-approved CRISPR-based therapy.

Location
Boston, Massachusetts, USA
Founded
1989
AUM
N/A (strategic investments)
Investment Range
$50M - $500M (partnerships)
Portfolio Companies
1
Focus
cvc
Fund Stages
series-a, series-b, series-c, growth

Portfolio Companies

NameLocationFoundedCategories
CRISPR TherapeuticsZug, Switzerland & Boston, Massachusetts, USA2013
therapeuticsbiotech+4